US4626841013 - Common Stock
IRIDEX CORP
NASDAQ:IRIX (5/7/2024, 12:06:01 PM)
2.8
-0.01 (-0.18%)
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 130 full-time employees. The Company’s laser consoles products consist of Glaucoma, which includes Cyclo G6 laser and delivery devices used for the treatment of glaucoma; Medical Retina product line, which includes IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases, and its PASCAL Synthesis Photocoagulator for the treatment of retinal diseases; Surgical Retina, which includes OcuLight TX, OcuLight SL and OcuLight SLx laser photocoagulation systems. The Company’s laser probes products consist of Glaucoma, which include MicroPulse P3 Probe, G-Probe and G-Probe Illuminate, and Surgical Retina probes, which include EndoProbe family of products used in vitrectomy procedures.
IRIDEX CORP
1212 Terra Bella Ave
Mountain View CALIFORNIA 94043
P: 16509404700
CEO: David I. Bruce
Employees: 130
Website: https://www.iridex.com/
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Iridex (NASDAQ:IRIX) just reported results for the fourth quarter of 2023.Iride...
Advances strategic review to unlock shareholder value
Advances strategic review to unlock shareholder value...
MOUNTAIN VIEW, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile...
Here you can normally see the latest stock twits on IRIX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: